bullish
Industry Report - Investment Opportunity in China Retail Pharmacy Market
265 Views10 Dec 2020 09:46
The article analyzed China retail pharmacy market, retail pharmacy chain, related policy, and highlight good investment opportunity such as Dashenlin, including its business performance and forecast.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
- China Healthcare Weekly (Dec.18)21 Dec 2020
- Industry Report - Insights on China Digital Healthcare Industry17 Dec 2020
- JD Health (6618.HK) - Opportunities Coexist with Challenges15 Dec 2020
- Industry Report - Investment Opportunity in China Retail Pharmacy Market10 Dec 2020
- Aier Eye Hospital(300015.CH) - The Largest Ophthalmic Chain in China with Promising Growth Potential09 Dec 2020
- Livzon Pharmaceutical (000513.CH) - A Good Company that You Can't Afford Missing02 Dec 2020
- 2021 High Conviction - Investment Opportunities in China Healthcare Industry23 Nov 2020
x